Current and emerging systemic therapies for cutaneous metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging systemic therapies for cutaneous metastatic melanoma

Published:2019-04-26 Issue:9 Volume:20 Page:1135-1152
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Mason Robert¹²,Au Lewis¹³,Ingles Garces Alvaro¹,Larkin James³⁴

Affiliation:

1. Clinical Research Fellow, Skin and Renal Units, The Royal Marsden Hospital, London, UK

2. Department of Medical Oncology, Gold Coast University Hospital, Southport, Queensland, Australia

3. Division of Clinical Research, The Institute of Cancer Research, London, UK

4. Consultant Oncologist, The Royal Marsden Hospital, London, UK

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1601700

Reference123 articles.

1. The RAF proteins take centre stage

2. Mutations of the BRAF gene in human cancer

3. Distinct Sets of Genetic Alterations in Melanoma

4. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

5. An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genistein transfersome-embedded topical delivery system for skin melanoma treatment: in vitro and ex vivo evaluations;Drug Delivery;2024-07

2. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma;Expert Review of Molecular Diagnostics;2024-02-05

3. A Fucose-Containing Sulfated Polysaccharide from Spatoglossum schröederi Potentially Targets Tumor Growth Rather Than Cytotoxicity: Distinguishing Action on Human Melanoma Cell Lines;Marine Biotechnology;2024-01-26

4. Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion;Discovery Medicine;2024

5. Validation Study of the PALCOM Scale of Complexity of Palliative Care Needs: A Cohort Study in Advanced Cancer Patients;Cancers;2023-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3